Section 23-79-1703 - State Board of Finance - Requirements(a) By the end of plan year 2017, the State Board of Finance shall explore the evidence supporting opportunities for benefit modification informed by: (1) The Choosing Wisely initiative;(2) Emerging therapies; and(3) Therapeutic alternatives to invasive surgical procedures, such as regenerative injection therapy.(b) By July 2018, the board shall: (1) Identify and consider implementation of pilot programs that include stepped therapy or center of excellence approaches, or both, for which evidence demonstrates cost savings to the plan; and(2) Identify opportunities to stimulate conversations between patients and providers about appropriate and necessary treatment, including treatment recommendations identified by the Choosing Wisely initiative.Amended by Act 2021, No. 1004,§ 24, eff. 4/28/2021.Added by Act 2017, No. 1089,§ 2, eff. 8/1/2017.